Endo Lurasidone is a stereoisomer of Lurasidone, characterized by a distinct configuration at its cyclohexane core. It retains the parent drug's essential framework, comprising a 1,2-benzisothiazol-3-yl-piperazine moiety linked via a methylene bridge to a 2-(methyliminooxy)cyclohexyl imide system. The 'endo' designation specifies a particular diastereomeric relationship concerning the spatial arrangement of the cyclohexane substituents relative to the imide, distinguishing it from Lurasidone's therapeutically active stereochemistry.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1A04960 โ | 25 mg | USD 596.25 |
S1N=C(C2=C1C=CC=C2)N2CCN(CC2)C[C@H]2[C@@H](CCCC2)CN2C([C@H]1[C@H]3CC[C@@H]([C@H]1C2=O)C3)=O
InChI=1S/C28H36N4O2S/c33-27-24-18-9-10-19(15-18)25(24)28(34)32(27)17-21-6-2-1-5-20(21)16-30-11-13-31(14-12-30)26-22-7-3-4-8-23(22)35-29-26/h3-4,7-8,18-21,24-25H,1-2,5-6,9-17H2/t18-,19+,20-,21-,24-,25+/m0/s1
PQXKDMSYBGKCJA-GGYSQDOYSA-N